Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GALSULFASE vs GEMFIBROZIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GALSULFASE vs GEMFIBROZIL: Safety Overview

Metric GALSULFASE GEMFIBROZIL
Total FAERS Reports 2,809 1,089
Deaths Reported 238 101
Death Rate 8.5% 9.3%
Hospitalizations 1,007 286
Average Patient Age 16.3 yrs 56.7 yrs
% Female Patients 53.7% 49.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer BioMarin Pharmaceutical Inc. Northwind Health Company, LLC
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued